Claforan

   
Google
 
Web NewDrugInformation.com

Claforan


Drug - Claforan
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefotaxime Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 1GM BASE/VIAL
The potency of the active ingredient(s), Cefotaxime Sodium. May repeat for multiple part products.

Applicant - AVENTIS PHARMS
The firm name holding legal responsibility for Claforan. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062659
The FDA assigned number to Claforan. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Claforan. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 13, 1987
The date Claforan was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Claforan. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Claforan is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Claforan.

Claforan